Baxter's Marked Vaccines

Pfizer Inc. (NYSE: PFE) is back on the M&A hunt, having agreed to acquire Anacor Pharmaceuticals Inc (NYSE: ANAC) for $5.2 billion. Ironically, it is nearly two years to the day from when AstraZeneca plc (ADR) (NYSE: AZN) rejected Pfizer's final offer to acquire the company for £...